Abstract

Liquid chromatography-mass spectrometry-based metabolomics studies are increasingly applied to large population cohorts, which run for several weeks or even years in data acquisition. This inevitably introduces unwanted intra- and inter-batch variations over time that can overshadow true biological signals and thus hinder potential biological discoveries. To date, normalisation approaches have struggled to mitigate the variability introduced by technical factors whilst preserving biological variance, especially for protracted acquisitions. Here, we propose a study design framework with an arrangement for embedding biological sample replicates to quantify variance within and between batches and a workflow that uses these replicates to remove unwanted variation in a hierarchical manner (hRUV). We use this design to produce a dataset of more than 1000 human plasma samples run over an extended period of time. We demonstrate significant improvement of hRUV over existing methods in preserving biological signals whilst removing unwanted variation for large scale metabolomics studies. Our tools not only provide a strategy for large scale data normalisation, but also provides guidance on the design strategy for large omics studies.

Highlights

  • Liquid chromatography-mass spectrometry-based metabolomics studies are increasingly applied to large population cohorts, which run for several weeks or even years in data acquisition

  • We compare against the performance of a number of recently developed and commonly used methods in popular pipelines when applied to large cohort studies, such as Support Vector Regression (SVR)[5], Systematic Error Removal using Random Forest (SERRF)[15], and Removal of Unwanted Variation based approaches[22,23] (Table 1)

  • We developed a series of technical replications designed as a framework to enable effective data harmonisation in large cohorts studies over extended periods of time

Read more

Summary

Introduction

Liquid chromatography-mass spectrometry-based metabolomics studies are increasingly applied to large population cohorts, which run for several weeks or even years in data acquisition This inevitably introduces unwanted intra- and inter-batch variations over time that can overshadow true biological signals and hinder potential biological discoveries. An in-house targeted metabolomics study was performed on a hospital-based cohort of patients with atherosclerosis (BioHEART- CT) was conducted based on the proposed sample arrangement strategy, and we utilise this to assess the normalisation on a number of criteria including retention of biological signal, low variability among replication, and reproducibility of results in comparison to other existing methods. The hRUV method is accessible as an R package and as a shiny application at https://shiny.maths.usyd.edu.au/hRUV/

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.